Pint Pharma is a biopharmaceutical company that specialises in the commercialisation of innovative therapies with the potential to transform outcomes in cancer, rare disease and other patient communities across the Latin American region. By collaborating with world-class biotech and pharma companies, Pint Pharma is committed to improving the lives of Latin American patients in areas of significant unmet medical need. The company is headquartered in Europe and counts with over 250 employees across its territories in Latin America including Brazil, Mexico, Argentina, Colombia, Chile, Peru and Ecuador.
| Website | http://www.pint-pharma.com |
| Revenue | $47.2 million |
| Employees | 262 (194 on RocketReach) |
| Founded | 1993 |
| Phone | +1 800-307-6627 |
| Technologies |
JavaScript
,
HTML
,
PHP
+9 more
(view full list)
|
| Industry | Pharmaceutical Manufacturing, Manufacturing General, Manufacturing |
| Keywords | Cutting Edge Therapies, Rare Diseases, Biotechnology, Pharmaceutical, Patient Access, Drug Development, Transformative Therapies, Innovative Treatments, Global Health, Clinical Trials, Healthcare, Medicine, Drug Delivery, Medical Research, Biopharma, Health Solutions |
| Competitors | Roche, Novartis, AbbVie, Merck & Co., Inc., GSK, Bristol Myers Squibb, Amgen, Teva Pharmaceuticals, Sandoz, Mylan Belgium +43 more (view full list) |
| SIC | SIC Code 28 Companies, SIC Code 283 Companies |
| NAICS | NAICS Code 325 Companies, NAICS Code 32 Companies, NAICS Code 32541 Companies, NAICS Code 3254 Companies |
Looking for a particular Pint Pharma employee's phone or email?
The Pint Pharma annual revenue was $47.2 million in 2026.
David Ricardo Munoz Guzman is the Founder and CEO of Pint Pharma.
194 people are employed at Pint Pharma.
Pint Pharma is based in Vienna, Vienna.
The NAICS codes for Pint Pharma are [325, 32, 32541, 3254].
The SIC codes for Pint Pharma are [28, 283].